A 2-week-old neonate presents with poor feeding, irritability, and a characteristic 'musty' or 'mousy' odor in urine and sweat. Serum phenylalanine is markedly elevated at 1200 µmol/L (normal <120 µmol/L). Which investigation is most appropriate to confirm the diagnosis and assess severity?

Explanation

## Diagnostic Approach to Elevated Phenylalanine ### Clinical Context The presentation of a neonate with elevated serum phenylalanine, musty odor (phenylacetate), poor feeding, and irritability is classic for **phenylketonuria (PKU)**. The diagnosis requires quantitative confirmation and assessment of the metabolic block. ### Why Plasma Amino Acid Profile (MS/MS) is Correct **Key Point:** Plasma amino acid profile by tandem mass spectrometry is the gold standard confirmatory test for PKU because it: - Quantifies **phenylalanine** and **tyrosine** levels simultaneously - Determines the **phenylalanine-to-tyrosine ratio** (typically >2 in classic PKU) - Identifies secondary tyrosine deficiency (tyrosine becomes essential when phenylalanine metabolism is blocked) - Allows classification into classic PKU, moderate PKU, or mild PKU based on Phe levels and ratio - Enables early intervention before neurological damage occurs **High-Yield:** The phenylalanine-to-tyrosine ratio is pathognomonic: - Classic PKU: Phe >1200 µmol/L, Phe/Tyr ratio >3 - Moderate PKU: Phe 400–1200 µmol/L - Mild PKU: Phe 120–400 µmol/L ### Biochemical Basis PKU results from deficiency of **phenylalanine hydroxylase**, the enzyme that converts phenylalanine to tyrosine. This causes: 1. Accumulation of phenylalanine in plasma and urine 2. Secondary deficiency of tyrosine (the product) 3. Shunting of excess Phe to alternative pathways → phenylacetate (musty odor), phenylpyruvate, phenylethylamine ### Why Other Investigations Are Insufficient | Investigation | Limitation | |---|---| | **Urine organic acids (GC-MS)** | Detects phenylpyruvate and phenylacetate (secondary metabolites) but does NOT quantify primary defect; less specific than plasma amino acids | | **Serum tyrosine alone** | Does not assess phenylalanine level or ratio; tyrosine may be low-normal in PKU, making isolated tyrosine measurement non-diagnostic | | **Ferric chloride test** | Qualitative screening test (turns green with phenylpyruvate); positive only when Phe >1200 µmol/L; NOT quantitative; too late for early intervention | **Clinical Pearl:** Modern newborn screening programs use **tandem MS (MS/MS)** on dried blood spots to detect elevated Phe/Tyr ratio within 24–48 hours of birth, enabling early dietary restriction and prevention of intellectual disability. ### Management Implication Once plasma amino acid profile confirms PKU, immediate dietary intervention (phenylalanine-restricted formula, e.g., Lofenalac) is started to maintain Phe <600 µmol/L and prevent neurotoxicity.